Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(5 sites)
United States
University of Florida, Gainesville, Gainesville, Florida The Cystic Fibrosis Institute, Northfield, Illinois New York Medical College/ Boston Children's Health Physicians, Hawthorne, New York Northwell Health Physicians, New York, New York Atrium Health Wake Forest Baptist Medical Center, Winston-Salem, North Carolina